The clinical evidence
Selank's anxiety data are not imaginary. Russian teams led by Zozulia and colleagues ran controlled comparisons against…
A real clinical record, in the wrong language
Selank's anxiety data are not imaginary. Russian teams led by Zozulia and colleagues ran controlled comparisons against benzodiazepines and reported comparable anxiety relief with a different side-effect profile. The catch is that this evidence lives almost entirely in Russian-language journals, indexed in English only as abstracts.
This unit examines what the trials actually showed, why the language barrier is a real scientific limitation and not a footnote, and how to read this unusual evidence base honestly.
Key terms
The Zozulia comparison
The foundational clinical study compared intranasal Selank against the benzodiazepine medazepam in patients with generalized anxiety disorder and neurasthenia. Over 14 days, anxiety reductions on the Hamilton and Zung scales were comparable between the two, but Selank added something medazepam lacked.
The headline is a genuine finding: in this trial, a peptide matched a benzodiazepine on anxiety scores while also producing anti-asthenic (anti-fatigue) effects and avoiding sedation. Improved plasma enkephalin half-life correlated with the response, tying the clinical result back to the mechanism. A later Russian comparison against the benzodiazepine phenazepam in 60 patients with phobic-anxiety and somatoform disorders reported the same shape of result, with a pronounced anxiolytic effect that persisted for about a week after the last dose (Medvedev 2014).
AdvancedWhy the enkephalin correlation strengthens it
A trial that only reports symptom scores can be hard to interpret. The Zozulia work is stronger because it linked improvement to a mechanistic biomarker: patients' plasma Leu-enkephalin half-life normalized during treatment and correlated with anxiety reduction. That mechanism-to-outcome bridge is a mark of quality, even within a small, single-language trial, because it makes a placebo-only explanation less likely.